Log in
NASDAQ:REGN

Regeneron Pharmaceuticals Short Interest Ratio and Short Volume

$508.31
+2.21 (+0.44 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$507.18
Now: $508.31
$515.47
50-Day Range
$506.10
MA: $568.54
$607.98
52-Week Range
$328.13
Now: $508.31
$664.64
Volume706,275 shs
Average Volume1.12 million shs
Market Capitalization$54.24 billion
P/E Ratio19.68
Dividend YieldN/A
Beta0.51

Short Interest

Regeneron Pharmaceuticals (NASDAQ:REGN) Short Interest Data

Current Short Volume:2,170,000 shares
Previous Short Volume:2,330,000 shares
Change Vs. Previous Month:-6.87%
Dollar Volume Sold Short:$1.23 billion
Short Interest Ratio / Days to Cover:2.0
Last Record Date:October, 30 2020
Outstanding Shares:107,730,000 shares
Float Size:102,000,000 shares
Short Percent of Float:2.13%
Today's Trading Volume:706,275 shares
Average Trading Volume:1,122,434 shares
Today's Volume Vs. Average:-37.08%



Regeneron Pharmaceuticals (NASDAQ:REGN) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
10/30/20202,170,000 $1.23 billion -6.9%2.1%2.4$566.43
10/15/20202,330,000 $1.36 billion 13.7%2.3%2.7$582.52
9/30/20202,050,000 $1.25 billion 28.1%2.0%2.4$607.98
9/15/20201,600,000 $918.50 million 0.6%1.6%2.1$574.06
8/31/20201,590,000 $880.59 million -0.6%1.6%2$553.83
8/14/20201,600,000 $948.29 million -15.3%1.6%1.4$592.68
7/31/20201,890,000 $1.17 billion -5.0%1.9%1.5$619.28
7/15/20201,990,000 $1.26 billion -6.1%1.9%1.5$632.07
6/30/20202,120,000 $1.29 billion -14.2%2.0%1.5$608.94
6/15/20202,470,000 $1.50 billion 24.1%2.3%1.7$605.33
5/29/20201,990,000 $1.20 billion 11.8%1.9%1.3$605.04
5/15/20201,780,000 $1.09 billion -4.8%2.1%1.2$612.81
4/30/20201,870,000 $1.02 billion -7.0%2.2%1.4$544.01
4/15/20202,010,000 $1.15 billion 12.9%2.5%1.5$574.11
3/31/20201,780,000 $1.01 billion -30.4%2.2%1.4$566.21
3/13/20202,558,900 $1.31 billion -11.2%3.1%2$512.96
2/28/20202,880,000 $1.31 billion 8.7%3.5%2.9$455.63
2/14/20202,650,000 $1.26 billion -8.3%3.2%3$475.02
1/31/20202,890,000 $1.32 billion 10.3%3.5%3.5$457.92
1/15/20202,620,000 $1.04 billion 5.7%3.2%3.4$396.75
12/31/20192,480,000 $856.29 million 0.8%3.0%3.4$345.28
8/15/20192,351,800 $669.63 million -7.4%2.9%2.8$284.73

Regeneron Pharmaceuticals (NASDAQ:REGN) Short Interest FAQ

speech bubbles
speech bubbles











What is Regeneron Pharmaceuticals' current short interest?

Short interest is the volume of Regeneron Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 30th, investors have sold 2,170,000 shares of REGN short. 2.13% of Regeneron Pharmaceuticals' shares are currently sold short. View details.

What is a good short interest ratio for Regeneron Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Regeneron Pharmaceuticals currently has a short interest ratio of 2.0.

What is a good short interest percentage for Regeneron Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.13% of Regeneron Pharmaceuticals' floating shares are currently sold short.

Is Regeneron Pharmaceuticals' short interest increasing or decreasing?

Regeneron Pharmaceuticals saw a drop in short interest in October. As of October 30th, there was short interest totaling 2,170,000 shares, a drop of 6.9% from the previous total of 2,330,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Regeneron Pharmaceuticals' float size?

Regeneron Pharmaceuticals currently has issued a total of 106,706,000 shares. Some of Regeneron Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Regeneron Pharmaceuticals currently has a public float of 102,000,000 shares.

How does Regeneron Pharmaceuticals' short interest compare to its competitors?

2.13% of Regeneron Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to Regeneron Pharmaceuticals: Amgen Inc. (1.22%), Gilead Sciences, Inc. (1.82%), Vertex Pharmaceuticals Incorporated (0.00%), Biogen Inc. (2.47%), Seagen Inc. (0.00%), Alexion Pharmaceuticals, Inc. (1.94%), Incyte Co. (0.00%), Exact Sciences Co. (0.00%), Alnylam Pharmaceuticals, Inc. (0.00%), and BioMarin Pharmaceutical Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.66 billion), Aon Plc ($3.83 billion), Analog Devices, Inc. ($3.33 billion), ViacomCBS Inc. ($3.13 billion), Snap Inc. ($3.05 billion), The Clorox Company ($2.85 billion), Uber Technologies, Inc. ($2.80 billion), Moderna, Inc. ($2.26 billion), Simon Property Group, Inc. ($2.02 billion), and International Flavors & Fragrances Inc. ($1.96 billion). View all of the most shorted stocks.

What does it mean to sell short Regeneron Pharmaceuticals stock?

Short selling REGN is an investing strategy that aims to generate trading profit from Regeneron Pharmaceuticals as its price is falling. Regeneron Pharmaceuticals' stock is trading up $2.21 today. To short Regeneron Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Regeneron Pharmaceuticals will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Regeneron Pharmaceuticals?

A short squeeze for Regeneron Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of REGN, which in turn drives the price of the stock up even further.

How often is Regeneron Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REGN, twice per month. The most recent reporting period available is October, 30 2020.


This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.